BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8985218)

  • 1. Polymorphisms within the human tumor necrosis factor-alpha promoter region in human immunodeficiency virus type 1-seropositive persons.
    Brinkman BM; Keet IP; Miedema F; Verweij CL; Klein MR
    J Infect Dis; 1997 Jan; 175(1):188-90. PubMed ID: 8985218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of a biallelic polymorphism in the tumor necrosis factor alpha promoter and HIV type 1 disease progression.
    Knuchel MC; Spira TJ; Neumann AU; Xiao L; Rudolph DL; Phair J; Wolinsky SM; Koup RA; Cohen OJ; Folks TM; Lal RB
    AIDS Res Hum Retroviruses; 1998 Mar; 14(4):305-9. PubMed ID: 9519891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Host genetic background at CCR5 chemokine receptor and vitamin D receptor loci and human immunodeficiency virus (HIV) type 1 disease progression among HIV-seropositive injection drug users.
    Barber Y; Rubio C; Fernández E; Rubio M; Fibla J
    J Infect Dis; 2001 Nov; 184(10):1279-88. PubMed ID: 11679916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The -137G/C polymorphism of interleukin 18 promoter and risk of HIV-1 infection and its progression to AIDS.
    Sobti RC; Sharma VL; Abitew AM; Berhane N; Mahdi SA; Askari M; Kuttiat VS; Wanchu A
    Acta Virol; 2011; 55(4):353-6. PubMed ID: 22149501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of interleukin-10 gene promoter polymorphisms on disease progression in patients chronically infected with hepatitis B virus.
    Miyazoe S; Hamasaki K; Nakata K; Kajiya Y; Kitajima K; Nakao K; Daikoku M; Yatsuhashi H; Koga M; Yano M; Eguchi K
    Am J Gastroenterol; 2002 Aug; 97(8):2086-92. PubMed ID: 12190181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A tumor necrosis factor-alpha-inducible promoter variant of interferon-gamma accelerates CD4+ T cell depletion in human immunodeficiency virus-1-infected individuals.
    An P; Vlahov D; Margolick JB; Phair J; O'Brien TR; Lautenberger J; O'Brien SJ; Winkler CA
    J Infect Dis; 2003 Jul; 188(2):228-31. PubMed ID: 12854077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TNF-alpha promoter region gene polymorphisms in HIV-positive patients with lipodystrophy.
    Maher B; Alfirevic A; Vilar FJ; Wilkins EG; Park BK; Pirmohamed M
    AIDS; 2002 Oct; 16(15):2013-8. PubMed ID: 12370499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stromal cell-derived factor 1 (SDF1) genetic polymorphism in a sample of healthy individuals, seronegative individuals exposed to human immunodeficiency virus type 1 (HIV-1) and patients infected with HIV-1 from the Brazilian population.
    Reiche EM; Watanabe MA; Bonametti AM; Morimoto HK; Morimoto AA; Wiechmann SL; Matsuo T; Miranda HC; Reiche FV; Oliveira KB
    Int J Immunogenet; 2006 Apr; 33(2):127-33. PubMed ID: 16611258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-1 envelope diversity 1 year after seroconversion predicts subsequent disease progression.
    Rachinger A; Kootstra NA; Gijsbers EF; van den Kerkhof TL; Schuitemaker H; van 't Wout AB
    AIDS; 2012 Jul; 26(12):1517-22. PubMed ID: 22555160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of CCR5-delta32, CCR2-64I and SDF-1-3'A polymorphic alleles on human immunodeficiency virus 1 (HIV-1) infection in the Polish population].
    Wasik TJ; Smoleń J; Kruszyński P; Bratosiewicz-Wasik J; Beniowski M
    Wiad Lek; 2005; 58(9-10):500-7. PubMed ID: 16529059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of HLA-C and HCP5 gene regions with the clinical course of HIV-1 infection.
    van Manen D; Kootstra NA; Boeser-Nunnink B; Handulle MA; van't Wout AB; Schuitemaker H
    AIDS; 2009 Jan; 23(1):19-28. PubMed ID: 19050382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of virologic, immunologic, and clinical parameters in infants with vertically acquired human immunodeficiency virus type 1 infection.
    Muñoz-Fernández MA; Obregón E; Navarro J; Börner C; Gurbindo MD; Sampelayo TH; Fernández-Cruz E
    Pediatr Res; 1996 Oct; 40(4):597-602. PubMed ID: 8888289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of polymorphism of tumor necrosis factor-alpha gene promoter region with outcome of hepatitis B virus infection.
    Li HQ; Li Z; Liu Y; Li JH; Dong JQ; Gao JR; Gou CY; Li H
    World J Gastroenterol; 2005 Sep; 11(33):5213-7. PubMed ID: 16127755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of DC-SIGN promoter polymorphism with increased risk for parenteral, but not mucosal, acquisition of human immunodeficiency virus type 1 infection.
    Martin MP; Lederman MM; Hutcheson HB; Goedert JJ; Nelson GW; van Kooyk Y; Detels R; Buchbinder S; Hoots K; Vlahov D; O'Brien SJ; Carrington M
    J Virol; 2004 Dec; 78(24):14053-6. PubMed ID: 15564514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between chronic hepatitis B virus infection and interleukin-10, tumor necrosis factor-alpha gene promoter polymorphisms.
    Cheong JY; Cho SW; Hwang IL; Yoon SK; Lee JH; Park CS; Lee JE; Hahm KB; Kim JH
    J Gastroenterol Hepatol; 2006 Jul; 21(7):1163-9. PubMed ID: 16824070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A tumor necrosis factor-alpha (TNF-alpha) promoter polymorphism is associated with chronic hepatitis B infection.
    Höhler T; Kruger A; Gerken G; Schneider PM; Meyer zum Büschenefelde KH; Rittner C
    Clin Exp Immunol; 1998 Mar; 111(3):579-82. PubMed ID: 9528902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergence of syncytium-inducing human immunodeficiency virus type 1 variants coincides with a transient increase in viral RNA level and is an independent predictor for progression to AIDS.
    Spijkerman I; de Wolf F; Langendam M; Schuitemaker H; Coutinho R
    J Infect Dis; 1998 Aug; 178(2):397-403. PubMed ID: 9697719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic restriction of HIV-1 pathogenesis to AIDS by promoter alleles of IL10.
    Shin HD; Winkler C; Stephens JC; Bream J; Young H; Goedert JJ; O'Brien TR; Vlahov D; Buchbinder S; Giorgi J; Rinaldo C; Donfield S; Willoughby A; O'Brien SJ; Smith MW
    Proc Natl Acad Sci U S A; 2000 Dec; 97(26):14467-72. PubMed ID: 11121048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor necrosis factor gene polymorphisms and clearance or progression of hepatitis B virus infection.
    Niro GA; Fontana R; Gioffreda D; Valvano MR; Lacobellis A; Facciorusso D; Andriulli A
    Liver Int; 2005 Dec; 25(6):1175-81. PubMed ID: 16343069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumour necrosis factor-alpha gene promoter region -308 and -376 G-->A polymorphisms in Behçet's disease.
    Duymaz-Tozkir J; Gül A; Uyar FA; Ozbek U; Saruhan-Direskeneli G
    Clin Exp Rheumatol; 2003; 21(4 Suppl 30):S15-8. PubMed ID: 14727453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.